Autopsy report · NCT02226315

Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies

“Slow enrollment of eligible subjects”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 1 month before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Sequenom, Inc.

Sponsor type

Industry

Conditions

Down Syndrome; Edwards Syndrome; Patau Syndrome; Turner Syndrome

Participants

50

Sites

1

Countries

United States

Trials that died the same way

• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
  “Slow subject enrollment” (93% match in meaning)
• High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma
  “slow enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.